Journal of Cancer Clinical Trials

ISSN: 2577-0535

Open Access

Chemotherapy-induced neutropenia and treatment


Chandrakanth Batra*

Platinum-based mix chemotherapy addresses the authentic first-line therapy in quite a while with cutting edge non-little cell cellular breakdown in the lungs (NSCLC), without targetable transformations, and great execution status (PS). During the '90s, this procedure turned into the norm of care because of a little however huge endurance advantage in grown-up patients. In any event, thinking about the new advances in treatment with focused specialists and resistant designated spot inhibitors, most patients are still possibility to get platinum-based chemotherapy. Chemotherapy-actuated neutropenia (CIN) is perhaps the most widely recognized unfavorable occasions revealed in malignant growth patients


Share this article

Google scholar citation report
Citations: 103

Journal of Cancer Clinical Trials received 103 citations as per google scholar report

Journal of Cancer Clinical Trials peer review process verified at publons

Indexed In

arrow_upward arrow_upward